Identification | Back Directory | [Name]
5H-Pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-6,7-dihydro-6-(methylamino)-, (6S)- | [CAS]
2238822-07-4 | [Synonyms]
5H-Pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-6,7-dihydro-6-(methylamino)-, (6S)- | [Molecular Formula]
C20H25N5O4S | [MOL File]
2238822-07-4.mol | [Molecular Weight]
431.51 |
Hazard Information | Back Directory | [Description]
GDC-2394 is a A Potent and Selective NLRP3 Inhibitor with an in vitro and in vivo safety profile suitable for advancement into human clinical trials. GDC 2394 Inhibits In Vivo Production of IL-1β in an Acute Mouse Peritonitis Model. GDC 2394 Reduces Paw Swelling and Pain in a Functional Rat Model of Gouty Arthritis. |
|
Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Website: |
http://www.is0513.com/ShowSupplierProductsList927327/0.htm |
|